List of speakers

More to come…

Frank Bennett, Ionis, USA

Roxana O Carare, Southampton, UK

Preclinical evaluation of a novel anti-tau vaccine based on UBITh peptide technology

Don Cleveland, UC San Diego, USA

Ilse Dewachter, Hasselt, Belgium

Michel Goedert, Cambridge, UK

Jürgen Götz, Brisbane, Australia

Tau in Alzheimer’s disease – from pathomechanistic studies to therapeutic ultrasound as a treatment modality

Bernard Hanseeuw, Louvain, Belgium

Eckhard Mandelkow, Germany

Pierre Maquet, Liège, Belgium

Ana Melo de Farias, Brazil & France

Alzheimer’s risk gene PTK2B effects TAU phosphorylation in human induced neurons

Tim Miller, MO, USA

Leonard Petrucelli, FL, USA

TMEM106b and tau

Naruhiko Sahara, Inage, Chiba, Japan

Dissecting mechanisms of tauopathy using in vivo multimodal imaging techniques on tauopathy mouse models

Wiep Scheper, Amsterdam, NL

Maria Grazia Spillantini, Cambridge, UK

Patrik Verstreken, Leuven, Belgium

Susanne Wegmann, Berlin, Germany